Miragen Therapeutics, Inc.

/Miragen Therapeutics, Inc.


Miragen Therapeutics, Inc.

They are a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapeutics with a specific focus on microRNAs and their roles in diseases where there is a high unmet medical need.



Price Range
$8.60 - $6.52

Anticipated Shares

Effective Date
February 9, 2018

Jefferies, Evercore ISI, Deutsche Bank

To view the prospectus for Miragen Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange